Skip to main content
NCBI home page
Heart logoLink to Heart
. 1996 Nov;76(3 Suppl 3):83–91. doi: 10.1136/hrt.76.3_suppl_3.83

Inhibitors of the renin-angiotensin system in established cardiac failure

Kanu Chatterjee 1
PMCID: PMC484494  PMID: 8977368

Full text

PDF
83

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ader R., Chatterjee K., Ports T., Brundage B., Hiramatsu B., Parmley W. Immediate and sustained hemodynamic and clinical improvement in chronic heart failure by an oral angiotensin-converting enzyme inhibitor. Circulation. 1980 May;61(5):931–937. doi: 10.1161/01.cir.61.5.931. [DOI] [PubMed] [Google Scholar]
  2. Chatterjee K., Rouleau J. L., Parmley W. W. Haemodynamic and myocardial metabolic effects of captopril in chronic heart failure. Br Heart J. 1982 Mar;47(3):233–238. doi: 10.1136/hrt.47.3.233. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Cohn J. N., Archibald D. G., Ziesche S., Franciosa J. A., Harston W. E., Tristani F. E., Dunkman W. B., Jacobs W., Francis G. S., Flohr K. H. Effect of vasodilator therapy on mortality in chronic congestive heart failure. Results of a Veterans Administration Cooperative Study. N Engl J Med. 1986 Jun 12;314(24):1547–1552. doi: 10.1056/NEJM198606123142404. [DOI] [PubMed] [Google Scholar]
  4. Cohn J. N., Johnson G., Ziesche S., Cobb F., Francis G., Tristani F., Smith R., Dunkman W. B., Loeb H., Wong M. A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure. N Engl J Med. 1991 Aug 1;325(5):303–310. doi: 10.1056/NEJM199108013250502. [DOI] [PubMed] [Google Scholar]
  5. Comparative effects of therapy with captopril and digoxin in patients with mild to moderate heart failure. The Captopril-Digoxin Multicenter Research Group. JAMA. 1988 Jan 22;259(4):539–544. [PubMed] [Google Scholar]
  6. Crozier I., Ikram H., Awan N., Cleland J., Stephen N., Dickstein K., Frey M., Young J., Klinger G., Makris L. Losartan in heart failure. Hemodynamic effects and tolerability. Losartan Hemodynamic Study Group. Circulation. 1995 Feb 1;91(3):691–697. doi: 10.1161/01.cir.91.3.691. [DOI] [PubMed] [Google Scholar]
  7. Davies R. F., Beanlands D. S., Nadeau C., Phaneuf D., Morris A., Arnold J. M., Parker J. O., Baigrie R., Latour P., Klinke W. P. Enalapril versus digoxin in patients with congestive heart failure: a multicenter study. Canadian Enalapril Versus Digoxin Study Group. J Am Coll Cardiol. 1991 Dec;18(7):1602–1609. doi: 10.1016/0735-1097(91)90491-q. [DOI] [PubMed] [Google Scholar]
  8. De Marco T., Chatterjee K., Rouleau J. L., Parmley W. W. Abnormal coronary hemodynamics and myocardial energetics in patients with chronic heart failure caused by ischemic heart disease and dilated cardiomyopathy. Am Heart J. 1988 Apr;115(4):809–815. doi: 10.1016/0002-8703(88)90883-6. [DOI] [PubMed] [Google Scholar]
  9. De Marco T., Daly P. A., Liu M., Kayser S., Parmley W. W., Chatterjee K. Enalaprilat, a new parenteral angiotensin-converting enzyme inhibitor: rapid changes in systemic and coronary hemodynamics and humoral profile in chronic heart failure. J Am Coll Cardiol. 1987 May;9(5):1131–1138. doi: 10.1016/s0735-1097(87)80318-2. [DOI] [PubMed] [Google Scholar]
  10. DiCarlo L., Chatterjee K., Parmley W. W., Swedberg K., Atherton B., Curran D., Cucci M. Enalapril: a new angiotensin-converting enzyme inhibitor in chronic heart failure: acute and chronic hemodynamic evaluations. J Am Coll Cardiol. 1983 Nov;2(5):865–871. doi: 10.1016/s0735-1097(83)80233-2. [DOI] [PubMed] [Google Scholar]
  11. Dickstein K., Chang P., Willenheimer R., Haunsø S., Remes J., Hall C., Kjekshus J. Comparison of the effects of losartan and enalapril on clinical status and exercise performance in patients with moderate or severe chronic heart failure. J Am Coll Cardiol. 1995 Aug;26(2):438–445. doi: 10.1016/0735-1097(95)80020-h. [DOI] [PubMed] [Google Scholar]
  12. Doherty N. E., 3rd, Seelos K. C., Suzuki J., Caputo G. R., O'Sullivan M., Sobol S. M., Cavero P., Chatterjee K., Parmley W. W., Higgins C. B. Application of cine nuclear magnetic resonance imaging for sequential evaluation of response to angiotensin-converting enzyme inhibitor therapy in dilated cardiomyopathy. J Am Coll Cardiol. 1992 May;19(6):1294–1302. doi: 10.1016/0735-1097(92)90337-m. [DOI] [PubMed] [Google Scholar]
  13. Erman A., Winkler J., Chen-Gal B., Rabinov M., Zelykovski A., Tadjer S., Shmueli J., Levi E., Akbary A., Rosenfeld J. B. Inhibition of angiotensin converting enzyme by ramipril in serum and tissue of man. J Hypertens. 1991 Nov;9(11):1057–1062. doi: 10.1097/00004872-199111000-00012. [DOI] [PubMed] [Google Scholar]
  14. Foult J. M., Tavolaro O., Antony I., Nitenberg A. Direct myocardial and coronary effects of enalaprilat in patients with dilated cardiomyopathy: assessment by a bilateral intracoronary infusion technique. Circulation. 1988 Feb;77(2):337–344. doi: 10.1161/01.cir.77.2.337. [DOI] [PubMed] [Google Scholar]
  15. Inoue T., Sakai Y., Morooka S., Hayashi T., Takayanagi K., Yamanaka T., Kakoi H., Takabatake Y. Coronary flow reserve in patients with dilated cardiomyopathy. Am Heart J. 1993 Jan;125(1):93–98. doi: 10.1016/0002-8703(93)90061-d. [DOI] [PubMed] [Google Scholar]
  16. Maisel A. S., Phillips C., Michel M. C., Ziegler M. G., Carter S. M. Regulation of cardiac beta-adrenergic receptors by captopril. Implications for congestive heart failure. Circulation. 1989 Sep;80(3):669–675. doi: 10.1161/01.cir.80.3.669. [DOI] [PubMed] [Google Scholar]
  17. Moravec C. S., Schluchter M. D., Paranandi L., Czerska B., Stewart R. W., Rosenkranz E., Bond M. Inotropic effects of angiotensin II on human cardiac muscle in vitro. Circulation. 1990 Dec;82(6):1973–1984. doi: 10.1161/01.cir.82.6.1973. [DOI] [PubMed] [Google Scholar]
  18. Neglia D., Parodi O., Gallopin M., Sambuceti G., Giorgetti A., Pratali L., Salvadori P., Michelassi C., Lunardi M., Pelosi G. Myocardial blood flow response to pacing tachycardia and to dipyridamole infusion in patients with dilated cardiomyopathy without overt heart failure. A quantitative assessment by positron emission tomography. Circulation. 1995 Aug 15;92(4):796–804. doi: 10.1161/01.cir.92.4.796. [DOI] [PubMed] [Google Scholar]
  19. Packer M., Medina N., Yushak M., Meller J. Hemodynamic patterns of response during long-term captopril therapy for severe chronic heart failure. Circulation. 1983 Oct;68(4):803–812. doi: 10.1161/01.cir.68.4.803. [DOI] [PubMed] [Google Scholar]
  20. Potkin B. N., Roberts W. C. Effects of percutaneous transluminal coronary angioplasty on atherosclerotic plaques and relation of plaque composition and arterial size to outcome. Am J Cardiol. 1988 Jul 1;62(1):41–50. doi: 10.1016/0002-9149(88)91362-8. [DOI] [PubMed] [Google Scholar]
  21. Sudhir K., MacGregor J. S., Gupta M., Barbant S. D., Redberg R., Yock P. G., Chatterjee K. Effect of selective angiotensin II receptor antagonism and angiotensin converting enzyme inhibition on the coronary vasculature in vivo. Intravascular two-dimensional and Doppler ultrasound studies. Circulation. 1993 Mar;87(3):931–938. doi: 10.1161/01.cir.87.3.931. [DOI] [PubMed] [Google Scholar]
  22. Treasure C. B., Vita J. A., Cox D. A., Fish R. D., Gordon J. B., Mudge G. H., Colucci W. S., Sutton M. G., Selwyn A. P., Alexander R. W. Endothelium-dependent dilation of the coronary microvasculature is impaired in dilated cardiomyopathy. Circulation. 1990 Mar;81(3):772–779. doi: 10.1161/01.cir.81.3.772. [DOI] [PubMed] [Google Scholar]
  23. Urata H., Kinoshita A., Misono K. S., Bumpus F. M., Husain A. Identification of a highly specific chymase as the major angiotensin II-forming enzyme in the human heart. J Biol Chem. 1990 Dec 25;265(36):22348–22357. [PubMed] [Google Scholar]
  24. White M., Rouleau J. L., Ruddy T. D., De Marco T., Moher D., Chatterjee K. Decreased coronary sinus oxygen content: a predictor of adverse prognosis in patients with severe congestive heart failure. J Am Coll Cardiol. 1991 Dec;18(7):1631–1637. doi: 10.1016/0735-1097(91)90495-u. [DOI] [PubMed] [Google Scholar]

Articles from Heart are provided here courtesy of BMJ Publishing Group

RESOURCES